# Comparing perioperative outcomes after transmetatarsal amputation in patients with or without peripheral vascular disease

**Authors:** Mark A. Plantz, Rachel Bergman, Erik Gerlach, Muhammad Mutawakkil, Milap Patel, Anish R. Kadakia

PMC · DOI: 10.1002/jfa2.70026 · Journal of Foot and Ankle Research · 2025-02-09

## TL;DR

This study compares outcomes of transmetatarsal amputation in patients with and without peripheral vascular disease, finding higher risks for those with vascular issues.

## Contribution

The study identifies that peripheral vascular disease is independently associated with higher reoperation and complication rates after transmetatarsal amputation.

## Key findings

- Patients with peripheral vascular disease had higher mortality, reoperation, and complication rates after TMA.
- A vascular surgical indication was independently linked to reoperation and medical complications.
- Infectious/diabetic wound patients had higher rates of deep surgical site infection and sepsis.

## Abstract

Transmetatarsal amputation (TMA) is a commonly performed procedure for gangrene in the setting of diabetes or peripheral vascular disease. The purpose of this study is to investigate the incidence of and risk factors for reoperation and perioperative complications after TMA in patients undergoing surgery for primarily infectious/diabetic wounds versus peripheral vascular disease.

Patients undergoing TMA between January 1, 2015 and December 31, 2020 were identified using the American College of Surgeons National Surgical Quality Improvement Program database. The indication for surgery was reported using the International Classification of Disease 9/10 codes. Patients were categorized into two groups: patients undergoing surgery for primarily infectious/diabetic wounds versus peripheral vascular disease. The incidence of 30‐day mortality, readmission, reoperation, nonhome discharge, and various medical and surgical complications was reported. Outcome measures were compared between the diabetic and peripheral vascular disease groups. Logistic regression was used to identify independent risk factors for each outcome measure of interest.

3392 patients were included in the final cohort. There was a 30‐day mortality rate of 2.9%, reoperation rate of 13.8%, readmission rate of 16.8%, surgical complication rate of 22.2%, and medical complication rate of 15.8%. Patients undergoing surgery for a vascular indication had a higher rate of mortality, reoperation, hospital readmission, nonhome discharge, and various medical complications (p < 0.05). Patients undergoing surgery for infectious/diabetic wounds had a higher rate of deep surgical site infection and systemic sepsis (p < 0.05). A vascular surgical indication was independently associated with reoperation and overall medical complications (p < 0.05). Various factors, including age, body mass index, medical comorbidities, and the presence of preoperative sepsis were associated with poor outcomes.

Significant rates of mortality, reoperation, and hospital readmission were reported after TMA. The presence of peripheral vascular disease was independently associated with reoperation and medical complications. Patients undergoing TMA, particularly for peripheral vascular disease, should be counseled about perioperative risks and indicated for surgery carefully.

## Linked entities

- **Diseases:** diabetes (MONDO:0005015), peripheral vascular disease (MONDO:0005294)

## Full-text entities

- **Diseases:** infectious (MESH:D003141), peripheral vascular disease (MESH:D016491), diabetes (MESH:D003920), sepsis (MESH:D018805), gangrene (MESH:D005734), infection (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11807761/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11807761/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC11807761/full.md

---
Source: https://tomesphere.com/paper/PMC11807761